Novel active compounds: The underlying technologies were transferred to the start-up through an exclusive license agreement ...

Max-Planck-Startup Ovo Labs entwickelt Medikamente, die den Erfolg bei Fruchtbarkeitsbehandlungen verbessern sollen ...